Another lncRNA, AGAP2-AS1, is also dysregulated in trastuzumab-resistant BC cells and plays a critical role in enhancing trastuzumab resistance by packaging into SEVs in an hnRNPA2B1-dependent manner [396]. This evidence concerns the gene AGAP2 and breast cancer.